#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
JOAN Perelló Email
CEO & co-founder . SANIFIT
How to contact JOAN Perelló
Join and see JOAN's contact info for free!Current Roles
Employees:
52Revenue:
$4MAbout
Sanifit is a biopharmaceutical company focused on the development of SNF472. The company was founded in 2007 as a spin-off of the University of the Balearic Islands and expanded its activities in the USA in 2016 with the incorporation of a subsidiary with offices in San Diego. SNF472 is an experimental drug for the treatment of cardiovascular diseases linked to calcification in the End Stage Renal Disease population undergoing haemodialysis. Sanifit has completed Phase I studies with healthy volunteers and haemodialysis patients, and after a recent series C funding round of $41.3M (?36.6M), Sanifit has launched two Phase II programs in ESRD and in the orphan space in calciphylaxis. For more information please visit www.sanifit.comSANIFIT Address
3655 Nobel DrivePalma de Mallorca, null